Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

31.65 -0.51 (-1.59%)

Official Closing Price Updated: 6:30 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic ↗

Today 11:20 EDT

Hims & Hers Health shares have rallied despite an FTC lawsuit over data sharing and billing practices, as weight-loss drug partnerships and Wall Street's cautious Hold rating shape the stock's outlook...

Via MarketBeat

Topics Lawsuit

Is Hims & Hers Health Stock in Trouble? ↗

August 03, 2026

In the past 12 months, the stock has nosedived more than 50%.

Via The Motley Fool

Bearish Pressure Is Building Around These 3 Stocks ↗

August 03, 2026

Hims & Hers Health and QXO face heavy short interest amid dilution and loss concerns, while KLA has slid nearly 40% since June as AI-driven chip spending fears grip semiconductor stocks.

Via MarketBeat

Topics Artificial Intelligence

1 Russell 2000 Stock with Exciting Potential and 2 We Ignore

August 03, 2026

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...

Via StockStory

Topics Economy

2 Growth Stocks with Explosive Upside and 1 That Underwhelm

July 31, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

Via StockStory

Topics Artificial Intelligence

2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore

July 30, 2026

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...

Via StockStory

Topics Energy

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

July 24, 2026

What Happened? A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The trend was highlighted in HC...

Via StockStory

Why Is Hims & Hers Health Stock Surging on Thursday? ↗

July 23, 2026

Hims & Hers Health Inc (NYSE: HIMS) stock surges Thursday after an FDA advisory committee votes on adding BPC-157 to the allowed pharmacy compounding list.

Via Benzinga

1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds

July 22, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 21, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 20.67% on an annualized basis producing an average annual return of 31.83%. Currently, Hims & Hers Health has a...

Via Benzinga

3 Reasons HIMS Has Explosive Upside Potential

July 17, 2026

Hims & Hers Health trades at $33.39 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time,...

Via StockStory

1 Stock Under $50 with Exciting Potential and 2 Facing Challenges

July 13, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 06, 2026

One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk.

Via The Motley Fool

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner ↗

July 06, 2026

Hims & Hers Health shares have surged 45% in 30 days on GLP-1 coverage shifts, but overbought technicals, a Hold rating, and rising short interest suggest a pullback may be near.

Via MarketBeat

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 01, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 17.4% on an annualized basis producing an average annual return of 28.89%. Currently, Hims & Hers Health has a...

Via Benzinga

Hims & Hers Stock Surges as Analysts Lift Price Targets ↗

July 01, 2026

Hims & Hers Health Inc (NYSE:HIMS) shares are rising on Wenesday after B of A Securities and Canaccord Genuity raised their respective price targets on the stock.

Via Benzinga

Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today ↗

June 23, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 14.14% on an annualized basis producing an average annual return of 25.67%. Currently, Hims & Hers Health has a...

Via Benzinga

June 23, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Via StockStory

1 Surging Stock Worth Your Attention and 2 We Find Risky

June 22, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

Topics Supply Chain

Hims & Hers Stock Jumps After Barclays Raises Price Target ↗

June 18, 2026

Hims & Hers Health (NYSE: HIMS) shares are climbing after Barclays reiterated its bullish stance and lifted its price target from $29 to $39.

Via Benzinga

Hims & Hers Stock Is Climbing Tuesday: What Investors Need To Know ↗

June 16, 2026

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher on Tuesday as the stock continues to rebound from recent profit-taking.

Via Benzinga

3 Market-Beating Stocks with Exciting Potential

June 16, 2026

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...

Via StockStory

Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock ↗

June 05, 2026

This telehealth stock has fallen hard, but its GLP-1 shift and global expansion could reshape the long-term story. Is the market too skeptical or still too optimistic?

Via The Motley Fool

1 Growth Stock Set to Flourishand 2 We Ignore

June 04, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

Via StockStory

Topics Economy

2 Unprofitable Stocks with Competitive Advantages and 1 Facing Headwinds

June 02, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

Is Hims & Hers Stock an Undervalued Stock to Buy? ↗

June 01, 2026

The healthcare industry is ripe for disruption.

Via The Motley Fool

Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗

May 28, 2026

Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes.

Via MarketBeat

Topics Earnings

Hims & Hers Shares Rally On Million-Dollar Insider Purchase ↗

May 27, 2026

Shares of Hims & Hers Health Inc (NYSE: HIMS) are trading higher Wednesday morning after insider stock purchase boosts investor confidence.

Via Benzinga

The Silver Lining of Last Week's Hims & Hers Earnings Miss ↗

May 21, 2026

Hims & Hers plunged 23% after a major Q1 earnings miss, but long-term growth stays intact via its Novo Nordisk GLP-1 partnership and a late 2026 expansion.

Via MarketBeat

Topics Earnings

Hims & Hers Massive Stock Drop Explained ↗

May 19, 2026

Raising debt increases the risk in Hims & Hers' stock.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

Headline News about Hims & Hers Health, Inc. Class A Common Stock

Starting at /week.